Outlook Therapeutics, Inc.

NASDAQ:OTLK

Biotechnology

Healthcare
$0.40 -5.76%

-$0.10 today

Market cap
$97.62M
Beta
0.98
P/E (TTM)
-2.1
EPS (TTM)
-$0.74
52W Low $0.16High $3.39

Volume 6.81M

Average 17.46M

Balance Sheet

Inspect the capital base behind the business.

Assets

$18.58M

FY 2025 · Annual

-35.5% YoY

Liabilities

$50.77M

FY 2025 · Annual

-50.2% YoY

Equity

-$32.19M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Sep 2021
FY 2022
Sep 2022
FY 2023
Sep 2023
FY 2024
Sep 2024
FY 2025
Sep 2025
Cash & Equivalents14.48M17.4M23.39M14.93M8.08M
Short-term Investments00000
Net Receivables00001.49M
Inventory00003.34M
Other Current Assets32407.59M12.49M4.48M
Total Current Assets21.51M27.52M30.98M27.42M17.39M
Property, Plant & Equipment (Net)275.05K70.36K26.17K274.65K225.51K
Goodwill00000
Intangible Assets00000
Long-term Investments853.66K804.93K793.93K693.19K552.18K
Tax Assets00000
Other Non-current Assets174.59K132.02K501.3K439.28K417.52K
Total Non-current Assets1.3M1.01M1.32M1.41M1.2M
Total Assets22.81M28.53M32.3M28.82M18.58M
Account Payables2.2M3.49M6.57M7.97M10.19M
Short-term Debt904.2K10.92M35.55M29.44M29.95M
Tax Payables1.86M1.86M1.86M1.86M302B
Deferred Revenue00000
Other Current Liabilities(217)1.45M1.83M1.01M3.03M
Total Current Liabilities6.75M19.73M46.73M42.55M45.81M
Long-term Debt10.89M0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities522.92K57.14K6.22K59.1M4.77M
Total Non-current Liabilities11.45M61.41K6.22K59.35M4.96M
Total Liabilities18.2M19.79M46.74M101.9M50.77M
Common Stock1.76M2.27M2.6M239.06K538.87K
Retained Earnings(342.88M)(408.94M)(467.92M)(543.28M)(605.71M)
Accumulated OCI(22.81T)417.67M(32.3T)00
Other Stockholders Equity(167)(28.53T)000
Minority Interest00000
Total Equity4.61M8.74M(14.44M)(73.08M)(32.19M)
Total Debt11.9M10.96M35.56M29.74M30.19M
Net Debt(2.57M)(6.44M)12.16M14.81M22.11M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$7.7M
Receivables$2.7M
Inventory$3.3T
Other Current-$3.3T
Total Current Assets$20.9M
PP&E (Net)$199.0K
Long-term Investments$468.4K
Other Non-current$320.3K
Total Non-current Assets$987.7K
Total Assets$21.9M

Analysis

Selected assets total $21.9M for Latest. The largest visible component is Inventory at $3.3T, about 15275808.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingOct 13, 2026
8-KCurrent reportSep 30, 2026
8-KCurrent reportSep 18, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
3Initial statement of beneficial ownershipSep 2, 2026

How much cash does OTLK have?

Outlook Therapeutics, Inc. (OTLK) reported $8.08M in cash and equivalents in fiscal 2025.

How much debt does OTLK carry?

Outlook Therapeutics, Inc. (OTLK) reported $30.19M of total debt, with net debt of $22.11M.